1. Home
  2. SRDX vs RYAM Comparison

SRDX vs RYAM Comparison

Compare SRDX & RYAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • RYAM
  • Stock Information
  • Founded
  • SRDX 1979
  • RYAM 1926
  • Country
  • SRDX United States
  • RYAM United States
  • Employees
  • SRDX N/A
  • RYAM N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • RYAM Paper
  • Sector
  • SRDX Health Care
  • RYAM Basic Materials
  • Exchange
  • SRDX Nasdaq
  • RYAM Nasdaq
  • Market Cap
  • SRDX 415.4M
  • RYAM 255.7M
  • IPO Year
  • SRDX 1998
  • RYAM N/A
  • Fundamental
  • Price
  • SRDX $29.92
  • RYAM $4.17
  • Analyst Decision
  • SRDX Buy
  • RYAM Buy
  • Analyst Count
  • SRDX 2
  • RYAM 1
  • Target Price
  • SRDX $43.00
  • RYAM $6.00
  • AVG Volume (30 Days)
  • SRDX 86.9K
  • RYAM 457.0K
  • Earning Date
  • SRDX 07-30-2025
  • RYAM 08-05-2025
  • Dividend Yield
  • SRDX N/A
  • RYAM N/A
  • EPS Growth
  • SRDX N/A
  • RYAM N/A
  • EPS
  • SRDX N/A
  • RYAM N/A
  • Revenue
  • SRDX $121,575,000.00
  • RYAM $1,598,619,000.00
  • Revenue This Year
  • SRDX N/A
  • RYAM N/A
  • Revenue Next Year
  • SRDX $3.70
  • RYAM $3.23
  • P/E Ratio
  • SRDX N/A
  • RYAM N/A
  • Revenue Growth
  • SRDX N/A
  • RYAM 2.20
  • 52 Week Low
  • SRDX $26.00
  • RYAM $3.45
  • 52 Week High
  • SRDX $42.44
  • RYAM $10.28
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 57.70
  • RYAM 60.31
  • Support Level
  • SRDX $28.90
  • RYAM $3.74
  • Resistance Level
  • SRDX $31.06
  • RYAM $4.24
  • Average True Range (ATR)
  • SRDX 0.85
  • RYAM 0.15
  • MACD
  • SRDX 0.08
  • RYAM 0.05
  • Stochastic Oscillator
  • SRDX 64.07
  • RYAM 86.79

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About RYAM Rayonier Advanced Materials Inc.

Rayonier Advanced Materials Inc is engaged in the production of cellulose specialties, a natural polymer used in the manufacturing of various specialty chemical products, including liquid crystal displays, filters, textiles and performance additives for pharmaceutical, food and other industrial applications. The company's products are used in a variety of applications, including cigarette filters, liquid crystal displays, paints, pharmaceuticals, and food. The company operates in the reportable segments of High Purity Cellulose, Paperboard, and High-Yield Pulp. The key revenue is derived from the High Purity Cellulose segment. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: